Status:
TERMINATED
A Long-term Follow-up Study of Patients Who Received VOR33
Lead Sponsor:
Vor Biopharma
Conditions:
Leukemia, Myeloid, Acute
Eligibility:
All Genders
Brief Summary
VOR33 long-term follow-up (LTFU) study
Detailed Description
VBP201 study is the VOR33 long-term follow-up (LTFU) study focusing on assessing long term safety and efficacy of VOR33. This study may last up to 15 years (counted from the date of VOR33 infusion com...
Eligibility Criteria
Inclusion
- A patient is included in this study if he/she:
- Has received any part of or all of a VOR33 infusion
Exclusion
- There are no exclusion criteria.
Key Trial Info
Start Date :
April 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 28 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05309733
Start Date
April 15 2022
End Date
May 28 2025
Last Update
July 29 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Diego Moores Cancer Center
La Jolla, California, United States, 92037
2
Miami Cancer Institute
Miami, Florida, United States, 33176
3
National Institutes of Health, Clinical Center
Bethesda, Maryland, United States, 20892
4
Washington University School of Medicine Siteman Cancer Center
St Louis, Missouri, United States, 63110